基于神经放射学的同行评议对头颈部放疗靶区勾画的影响
研究纳入了7个月内80例头颈部放疗计划质量保证病例(根治性48%、术后52%),将计划CT与靶区同诊断影像对照复核并记录修改。44例(55%)靶区被修改,其中61%为有临床意义的改变,导致特定区域或结构被排除或纳入;体积变化更常见为增加(73%)而非减少(27%)。作者认为神经放射学参与的协作性质控对靶区勾画有影响,具有挑战性浸润、颅内、淋巴结、眶内或神经周围扩散模式的病例值得与诊断神经放射科医生协作进行密集的影像学复核。
要点
- 80例头颈部放疗计划复核中44例(55%)靶区被修改,其中61%为有临床意义的改变。
- 修改原因以大体或残留肿瘤(26/44,59%)和选择性或术后覆盖(25/44,57%)最常见。
- 大体肿瘤体积变化范围为0.5%至133.64%,体积变化中位数为5.95 mm3(7.86%)。
核心结论
- 头颈部放疗计划质量保证的协作方式有实际影响;具有挑战性浸润、颅内、淋巴结、眶内或神经周围扩散模式的病例值得与诊断神经放射科医生协作进行密集的影像学复核。
研究设计与样本
- 单中心质量保证项目描述,7个月内纳入80例头颈部放疗计划质量保证病例(根治性48%、术后52%),将计划CT及相关靶区与诊断影像学研究对照复核并记录修改。
关键影像表现/征象
- 80例中44例(55%)靶区被修改,其中61%为有临床意义的改变,导致特定区域或结构被排除或纳入。
- 修改原因包括大体或残留肿瘤26/44(59%)、选择性或术后覆盖25/44(57%)、淋巴结13/44(30%)、骨7/44(16%)、颅底7/44(16%)、正常器官5/44(11%)、神经周围3/44(7%)、远处转移2/44(5%)、眼1/44(2%)。
- 大体肿瘤变化范围为0.5%至133.64%,体积变化中位数为5.95 mm3(7.86%)。
- 体积更常见为增加(73%)而非减少(27%)。
临床应用与阅片要点
- 作者认为,具有挑战性浸润、颅内、淋巴结、眶内或神经周围扩散模式的病例值得与诊断神经放射科医生协作进行密集的影像学复核。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: While standard guidelines assist in target delineation for head and neck radiation therapy planning, the complex anatomy, varying patterns of spread, unusual or advanced presentations, and high risk of treatment-related toxicities produce continuous interpretive challenges. In 2007, we instituted weekly treatment planning quality assurance rounds as a joint enterprise of head and neck radiation oncology and neuroradiology. Here we describe its impact on head and neck radiation therapy target delineation.
MATERIALS AND METHODS: For 7 months, treatment planning quality assurance included 80 cases of definitive (48%) or postoperative (52%) head and neck radiation therapy. The planning CT and associated target volumes were reviewed in comparison with diagnostic imaging studies. Alterations were catalogued.
RESULTS: Of the 80 cases, 44 (55%) were altered, and of these, 61% had clinically significant changes resulting in exclusion or inclusion of a distinct area or structure. Reasons for alteration included the following: gross or extant tumor, 26/44 (59%); elective or postoperative coverage, 25/44 (57%); lymph nodes, 13/44 (30%); bone, 7/44 (16%); skull base, 7/44 (16%); normal organs, 5/44 (11%); perineural, 3/44 (7%); distant metastasis, 2/44 (5%); and eye, 1/44 (2%). Gross tumor changes ranged from 0.5% to 133.64%, with a median change in volume of 5.95 mm3 (7.86%). Volumes were more likely to be increased (73%) than decreased (27%).
CONCLUSIONS: A collaborative approach to head and neck treatment planning quality assurance has an impact. Cases likely to have challenging patterns of infiltrative, intracranial, nodal, orbital, or perineural spread warrant intensive imaging-based review in collaboration with a diagnostic neuroradiologist.
引用
- Braunstein S, Glastonbury CM, Chen J, et al. Impact of Neuroradiology-Based Peer Review on Head and Neck Radiotherapy Target Delineation. AJNR Am J Neuroradiol. 2016. PMID: 27811130. doi:10.3174/ajnr.A4963
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。